StockNews.com began coverage on shares of NuVasive (NASDAQ:NUVA – Free Report) in a research report report published on Sunday. The firm issued a hold rating on the medical device company’s stock. NUVA has been the subject of a number of other research reports. Truist Financial upped their price target on NuVasive from $48.00 to $51.00 […]